FDA expanding access to pancreatic cancer drug to some patients
The FDA this week announced it would be expanding access to a promising pancreatic cancer drug that nearly doubled survival time for patients with advanced pancreatic cancer in a large clinical trial.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
Michael
Veteran Owned and Operated Business
